212 related articles for article (PubMed ID: 22133608)
1. Fatal intracerebral hemorrhage associated with administration of recombinant tissue plasminogen activator in a stroke patient on treatment with dabigatran.
Casado Naranjo I; Portilla-Cuenca JC; Jiménez Caballero PE; Calle Escobar ML; Romero Sevilla RM
Cerebrovasc Dis; 2011; 32(6):614-5. PubMed ID: 22133608
[No Abstract] [Full Text] [Related]
2. Fibrinolytic treatment of acute ischemic stroke for patients on new oral anticoagulant drugs.
Dempfle CE; Hennerici MG
Cerebrovasc Dis; 2011; 32(6):616-9. PubMed ID: 22133643
[No Abstract] [Full Text] [Related]
3. Acute ischemic stroke treated with intravenous tissue plasminogen activator in a patient taking dabigatran with radiographic evidence of recanalization.
Sangha N; El Khoury R; Misra V; Lopez G
J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):917.e5-8. PubMed ID: 22683118
[TBL] [Abstract][Full Text] [Related]
4. Good outcome after intravenous thrombolysis for acute stroke in a patient under treatment with dabigatran.
Diogo C; Duarte J; Sobral S; Pestana P; Nzwalo H; Rita H; Sousa E Costa J
Am J Emerg Med; 2014 Nov; 32(11):1435.e1-2. PubMed ID: 24881517
[TBL] [Abstract][Full Text] [Related]
5. Dabigatran-related intracerebral hemorrhage resulting in hematoma expansion.
Simonsen CZ; Steiner T; Tietze A; Damgaard D
J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):e133-4. PubMed ID: 24103671
[TBL] [Abstract][Full Text] [Related]
6. Intravenous tissue plasminogen activator treatment for ischemic stroke in dabigatran-treated patients.
Takeuchi S; Wada K; Nagatani K; Otani N; Osada H; Nawashiro H
Acta Neurochir (Wien); 2012 Jan; 154(1):87. PubMed ID: 22037979
[No Abstract] [Full Text] [Related]
7. Dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
Edwards DB; Silverberg J
Ann Intern Med; 2011 Apr; 154(8):570; author reply 570-1. PubMed ID: 21502658
[No Abstract] [Full Text] [Related]
8. Dabigatran for stroke prevention in all patients with atrial fibrillation?
Hunchuck JE; Lake JD
Pharmacotherapy; 2011 Aug; 31(8):725-8. PubMed ID: 21923597
[No Abstract] [Full Text] [Related]
9. Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion.
Nagarakanti R; Ezekowitz MD; Oldgren J; Yang S; Chernick M; Aikens TH; Flaker G; Brugada J; Kamensky G; Parekh A; Reilly PA; Yusuf S; Connolly SJ
Circulation; 2011 Jan; 123(2):131-6. PubMed ID: 21200007
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacological sheet. Dabigatran, oral administration (Pradaxa)].
Duh PD; Leuckx PS; Warnez PM
J Pharm Belg; 2012 Mar; (1):37-8. PubMed ID: 22536682
[No Abstract] [Full Text] [Related]
11. Thrombolysis with recombinant tissue plasminogen activator under dabigatran anticoagulation in experimental stroke.
Pfeilschifter W; Bohmann F; Baumgarten P; Mittelbronn M; Pfeilschifter J; Lindhoff-Last E; Steinmetz H; Foerch C
Ann Neurol; 2012 May; 71(5):624-33. PubMed ID: 22447744
[TBL] [Abstract][Full Text] [Related]
12. Reducing hemorrhagic complication by dabigatran via neurovascular protection after recanalization with tissue plasminogen activator in ischemic stroke of rat.
Kono S; Deguchi K; Omote Y; Yunoki T; Yamashita T; Kurata T; Ikeda Y; Abe K
J Neurosci Res; 2014 Jan; 92(1):46-53. PubMed ID: 24265137
[TBL] [Abstract][Full Text] [Related]
13. Intravenous thrombolysis in a stroke patient taking dabigatran.
Lee VH; Conners JJ; Prabhakaran S
J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):916.e11-2. PubMed ID: 22608344
[TBL] [Abstract][Full Text] [Related]
14. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M;
Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865
[TBL] [Abstract][Full Text] [Related]
15. Thrombolysis in an ischemic stroke patient on dabigatran anticoagulation: a case report.
Marrone LC; Marrone AC
Cerebrovasc Dis; 2012; 34(3):246-7. PubMed ID: 23018342
[No Abstract] [Full Text] [Related]
16. Dabigatran-related coagulopathy: when can we assume the effect has "worn off"?
Pollack CV; Levy JH; Eikelboom J; Weitz JI; Sellke FW; Huisman MV; Steiner T; Kamphuisen P; Bernstein RA
Am J Emerg Med; 2014 Nov; 32(11):1433-4. PubMed ID: 25239691
[No Abstract] [Full Text] [Related]
17. [New concepts in the therapy of atrial fibrillation].
Shin DI; Eckardt L
Dtsch Med Wochenschr; 2011 Aug; 136(31-32):1587-90. PubMed ID: 21809248
[No Abstract] [Full Text] [Related]
18. Cost-effectiveness of dabigatran for stroke prophylaxis in atrial fibrillation.
Shah SV; Gage BF
Circulation; 2011 Jun; 123(22):2562-70. PubMed ID: 21606397
[TBL] [Abstract][Full Text] [Related]
19. Endovascular thrombectomy for acute ischemic stroke patients anticoagulated with dabigatran.
Müller P; Topakian R; Sonnberger M; Nußbaumer K; Windpessl M; Eder V; Nesser HJ; Trenkler J; Haring HP
Clin Neurol Neurosurg; 2013 Oct; 115(10):2257-9. PubMed ID: 23921437
[No Abstract] [Full Text] [Related]
20. Treatment of acute stroke in patients on dabigatran: a survey of US stroke specialists.
Rybinnik I; Mullen MT; Messe S; Kasner SE; Cucchiara B
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):1312-6. PubMed ID: 23313461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
